DS: Pakistan — Patent Protection for Pharmaceutical and Agricultural Chemical Products

This summary has been prepared by the Secretariat under its own responsibility. The summary is for general information only and is not intended to affect the rights and obligations of Members.


See also:

back to top

Current status


back to top

Key facts


back to top

Latest document


back to top

Summary of the dispute to date

The summary below was up-to-date at


Complaint by the United States.

In its request for consultations dated 30 April 1996, the United States claimed that the absence in Pakistan of (i) either patent protection for pharmaceutical and agricultural chemical products or a system to permit the filing of applications for patents on these products and (ii) a system to grant exclusive marketing rights in such products, violates TRIPS Agreement Articles 27, 65 and 70. On 3 July 1996, the United States requested the establishment of a panel. The DSB considered the request at its meeting on 16 July 1996, but did not establish a panel due to Pakistan’s objection.


Mutually agreed solution

At the DSB meeting on 25 February 1997, both parties informed the DSB that they had reached a mutually agreed solution to the dispute and that the terms of the agreement were being drawn up, and would be communicated to the DSB once finalized. On 28 February 1997, the terms of the agreement were communicated to the Secretariat.


Follow this dispute


Problems viewing this page? If so, please contact [email protected] giving details of the operating system and web browser you are using.